#158 IT: InSilicoTrials Technologies Innovation Theater: Are Human Patients Needed for Clinical Trials, Tomorrow?

#158 IT: InSilicoTrials Technologies Innovation Theater: Are Human Patients Needed for Clinical Trials, Tomorrow?

Monday, June 17, 2024 4:45 PM to 5:15 PM · 30 min. (US/Pacific)
Exhibit Hall Theater #1
19: InnovationTheaters

Information

Chart your new horizons by pioneering on the edge of Gen AI-powered In Silico Data Modeling. Proven case studies will be shared in a panel session from regulatory, sponsor and CRO perspectives. Learn how InSilicoTrials has enhanced drug dosing, trial performance, and patient safety across targeted populations. Discover significant reductions in time and costs—achieving up to a 90% efficiency in specific R&D activities—while upholding the highest standards of patient safety.

Don't miss the chance to receive an autographed complimentary copy of the publication "Toward Good Simulation Practice," co-authored by our CEO, Luca Emili, with the contribution of 13+ FDA leaders. This book is a cornerstone in promoting reliable and efficient In Silico Trials solutions, reflecting a major stride in medical research and development.
InSilicoTrials1006InSilicoTrials aims to become the premier problem solver in drug development by leveraging computational modeling and simulation (in silico) techniques. Using AI and advanced predictive technologies, we support emerging biotech companies by generating robust digital evidence that enhances funding prospects and clinical outcomes. Our in silico methods reduce R&D time and costs, offering: Virtual Patient and AI-enhanced trial accuracy. Cloud-based simulations for comprehensive virtual assessments. Regulatory-compliant data to support clinical programs. We are an international team of professionals ​coming from healthcare, regulatory, engineering simulation, IT, cloud, and cybersecurity. We work with a network of 70+ prestigious universities and research centers worldwide and we are currently part of 5 EU-funded projects that are really making a difference in healthcare: SimCardioTest, Brainteaser, In Silico World, Disc4All and Metastra. Our unique cloud platform offers Pharma companies state-of-the-art simulation tools that can highly reduce the cost and time of medical products development, while increasing their safety and efficacy. We collaborate with top international regulators such as the FDA and EMA, that have been encouraging for years the adoption of in silico methods in healthcare. We share a vision: to deeply innovate the healthcare industry through state-of-the-art technology, which means less tests on humans and animals, and more treatments, new medicines and safer medical products for millions of people worldwide. Our commitment has not gone unnoticed: we are proud recipients of the AI Startup of the Year Award by Startup Grind Global 2024, and of the Innovation Radar Prize 2023 by the European Commission in the AI & Smart Devices category. Live longer, live better.

Registered attendees

Adam Kaplin
Adam Kaplin
Chief Scientific and Clinical Innovation OfficerMiralogx
Alison Cave
Alison Cave
Chief Safety OfficerMedicines and Healthcare Products Regulatory Agency (MHRA)
Bill Byrom
Bill Byrom
Vice President, Product Intelligence and Positioning; Principal, eCOA ScienceSignant Health

Log in

See all the content and easy-to-use features by logging in or registering!